Apollo Endosurgery, Inc.: Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates
Revenue expected between $16.0 million and $16.4 millionThird consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30%Submitted a De Novo 510(k) Classification Request to FDA
Source: finanznachrichten.de